Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech sector, but industry leaders believe science may carry the day.
source https://www.seattletimes.com/business/as-trump-and-rfk-jr-move-to-upend-drug-making-seattle-biotech-bets-on-science/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment